Joel B. Epstein

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

April, 2025

Joel B. Epstein

Aug 9, 2024, 03:12 | Blog

Noam Yarom: First consensus paper addressing the risk of Medication-related Osteonecrosis of the Jaw in patients with primary breast cancer

Noam Yarom, President at International Society Oral Oncology shares a post on LinkedIn: "Our latest Clinical…

Aug 1, 2024, 15:23 | Insight

Alessandro Villa: The management of oral toxicities secondary to targeted therapy

Alessandro Villa, Chief of Oral Medicine, Oral Oncology, and Dentistry at Baptist Health, shared a post on…

All: 2 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023